Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Polycystic Ovary Syndrome 6Squamous Cell Carcinoma of Head and Neck 2Obesity 2Endometrial Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Diseases 1Insulin Resistance 1Inflammation 1Head and Neck Squamous Cell Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Diabetes Mellitus 1Barrett Esophagus 1

Interventions

Radiotherapy, Intensity-Modulated 1Nivolumab 1Metformin 1Ipilimumab 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Lymphoid Interstitial Pneumonia × Metformin × Clear all
NCT03109873 2025-04-30

Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
9 enrolled 6 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡